Alkermes PLC
(NAS:ALKS)
$
27.84
0.09 (0.32%)
Market Cap: 4.58 Bil
Enterprise Value: 4.06 Bil
PE Ratio: 16.57
PB Ratio: 3.60
GF Score: 67/100 Alkermes Plc at Leerink Partners Global Healthcare Conference Transcript
Feb 27, 2019 / 07:30PM GMT
Release Date Price:
$31.8
(+0.85%)
Marc Harold Goodman
SVB Leerink LLC, Research Division - MD of Neuroscience & Senior Research Analyst
We're going to get started. Could you just close that back door.
Thank you, good afternoon, everybody. So I'm Marc Goodman, and our next session is with Rich Pops, who's the CEO of Alkermes. And Rich and I were just talking about, I couldn't believe how long Rich has been running the company. 1991, he's been the CEO. So, I mean, you've got to be one of the longest-running CEOs in biopharma, I would have to think, if not the longest running. So congrats on that.
Richard F. Pops
Alkermes plc - Chairman & CEO
They say, unemployable anywhere else.
Marc Harold Goodman
SVB Leerink LLC, Research Division - MD of Neuroscience & Senior Research Analyst
So Richard has got to have some opening comments, and then we'll jump into a chat. So go ahead. And thank you Rich for joining us.
Richard F. Pops
Alkermes plc - Chairman & CEO
Good to see Marc. Haven
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot